文献速递烧伤创面修复瘢痕与激光

Marjolin溃疡:单中心经验与分期系统评估

Marjolin ulcer: A single-center experience and evaluation of staging systems.
PubMed 文献 · Burns · 2026-06-03

回顾性分析42例Marjolin溃疡患者,应用中AJCC第8版和BWH分期系统均无法区分复发或死亡风险。探索性应用口腔鳞癌浸润深度阈值发现,DOI≤5mm无远处转移,而DOI>10mm者复发率80%、远处转移率60%。病理淋巴结转移是RFS最强独立预测因子(HR 5.91)。

要点

  • 现有cSCC分期系统(AJCC第8版、BWH)在Marjolin溃疡中未能有效分层预后。
  • DOI>10mm者复发率80%、远处转移率60%,DOI≤5mm者无远处转移。
  • 病理淋巴结转移是RFS最强独立预测因子(HR 5.91,p=0.012)。

核心结论

  • 现行分期系统无法对Marjolin溃疡结局进行分层。
  • 需在未来系列中标准化报告DOI(mm)及病理淋巴结状态以建立疾病特异性分期。

研究设计与样本

  • 单中心回顾性队列研究,纳入2010–2025年连续42例Marjolin溃疡患者。

主要发现

  • 队列以男性为主(71%),平均年龄54岁;烧伤为首要病因(67%),下肢最常见(69%)。
  • 中位随访48个月,复发率26.2%,总死亡率21.4%。
  • AJCC系统将71%肿瘤归为T3,未能区分复发(p=0.537)或死亡(p=0.760);BWH分期同样无显著性。
  • AJCC皮肤SCC深度阈值6mm对复发无区分力(p=0.477)。
  • 探索性应用口腔SCC DOI阈值:DOI≤5mm者无远处转移(0/23),DOI>10mm者复发80%、远处转移60%(log-rank p<0.001)。

关键数值与推荐

  • AJCC第8版和BWH分期系统均未显示对复发或死亡有显著分层能力。
  • AJCC皮肤SCC DOI阈值6mm对复发无显著区分(p=0.477)。
  • 口腔SCC DOI阈值5mm和10mm在探索性分析中与远处转移和复发显著相关(log-rank p<0.001)。

临床怎么用

  • 临床不应依赖现有cSCC分期系统对Marjolin溃疡进行预后判断。
  • 应标准化报告肿瘤DOI(mm)和病理淋巴结状态以支持未来疾病特异性分期。

局限性

  • 单中心回顾性设计,样本量42例。
  • 口腔SCC DOI阈值为探索性分析,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Marjolin ulcer lacks a disease-specific staging system, and existing cutaneous squamous cell carcinoma (cSCC) staging criteria have never been formally tested against outcomes in this disease. METHODS: We retrospectively reviewed 42 consecutive Marjolin ulcer patients treated at a single tertiary center between 2010 and 2025, applied the American Joint Committee on Cancer (AJCC) 8th edition and Brigham and Women's Hospital (BWH) staging systems, and analyzed clinicopathological predictors of recurrence and survival including tumor depth of invasion (DOI) in millimeters. RESULTS: The cohort was predominantly male (71%) with a mean age of 54 years; burns were the leading etiology (67%), and the lower extremity was the most common site (69%). At median follow-up of 48 months, recurrence occurred in 26.2% and overall mortality in 21.4%. The AJCC system classified 71% of tumors as T3 and did not discriminate recurrence (p = 0.537) or mortality (p = 0.760). BWH staging was similarly nonsignificant. The AJCC cutaneous SCC depth threshold of 6 mm failed for recurrence (p = 0.477). When oral cavity SCC DOI thresholds were applied as an exploratory framework, patients with DOI ≤ 5 mm had no distant metastasis (0/23), whereas those with DOI > 10 mm had 80% recurrence and 60% distant metastasis (log-rank p < 0.001). Pathological nodal metastasis was the strongest independent predictor of recurrence-free survival (HR 5.91; p = 0.012). CONCLUSIONS: Current staging systems fail to stratify outcomes in Marjolin ulcer. Standardized reporting of DOI in millimeters alongside pathological nodal status across future series is needed for disease-specific staging and treatment algorithms.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Rador MC, Ofluoğlu AC, Pala A, et al. Marjolin ulcer: A single-center experience and evaluation of staging systems. Burns. 2026. PMID: 42296602. doi:10.1016/j.burns.2026.108103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。